Noble Corporation PLC (NE) Stock News

Rosen Law Firm reminds Papa John's International investors of the November 2, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Papa John's made materially false statements about its transformation efforts, which were taking longer than expected and failed to prevent market share losses, requiring a shift toward increased promotional efforts.

Western New England Bancorp reported Q3 2026 revenue of $23.9 million, up 12.4% year-over-year, beating consensus estimates by 1.16%. EPS of $0.32 significantly exceeded the $0.26 estimate by 23.08%. Key metrics including net interest margin (3.1%), efficiency ratio (69.1%), and net interest income ($19.99 million) all met or slightly exceeded analyst expectations. The stock carries a Zacks Rank #3 (Hold) rating.

Pomerantz LLP is investigating potential securities fraud claims against Neogen Corporation following an FDA warning letter regarding its veterinary wound care product HYCOAT, which was linked to at least 20 horse deaths—the largest number of deaths associated with a quality defect in an FDA-regulated veterinary product. Neogen initiated a voluntary recall in January 2026, and the stock fell 7.22% on the news.

NextEra Energy (NEE) and Southern Company (SO) are compared as leading U.S. electric utilities investing heavily in renewable energy. NEE shows stronger earnings growth projections (8.63-8.77% for 2026-2027), lower debt levels (60.99% debt-to-capital), and higher capital investment plans ($94.1B through 2030). SO leads in dividend yield (3.28%) and ROE (12.93%), but trades at a similar valuation. Both companies hold Zacks Rank #3 (Hold), with NEE appearing to have a slight edge overall.

Innventure, Inc. (NASDAQ: INV) faces a securities class action lawsuit after its stock plummeted 55-74% in August 2026. The company allegedly misled investors about the viability of the DarkNX project, a purported 300MW AI data center deployment in Ontario, Canada. Forensic research revealed the project likely doesn't exist, with former executives and employees contradicting the company's claims. Innventure subsequently removed the project from its bookings and suspended revenue guidance. The lead plaintiff deadline for the class action is October 27, 2026.

Rosen Law Firm announces a securities class action lawsuit against XTI Aerospace, Inc. for investors who purchased securities between April 15, 2026 and August 17, 2026. The lawsuit alleges that senior executives engaged in undisclosed activities requiring Board review, raising doubts about disclosure controls and the company's ability to file timely earnings reports. The lead plaintiff deadline is October 27, 2026.

Rosen Law Firm is notifying investors about securities class action lawsuits against DICK'S Sporting Goods and FuelCell Energy. The DKS lawsuit alleges the company made false statements about its Foot Locker acquisition cleanup and failed to disclose exposure to excess inventory and promotional pressures in the athletic footwear industry, resulting in inability to achieve promised sales growth and profits. Investors who purchased shares during specified periods may be eligible for compensation, with a November 3, 2026 deadline to serve as lead plaintiff.

Securities class action lawsuits have been filed against four publicly traded companies alleging fraud and misleading statements. Hyliion Holdings is accused of announcing a deal with a recently formed entity with no real operations to inflate stock prices. XTI Aerospace faces allegations of undisclosed executive activities and disclosure control failures. Innventure is accused of overstating revenue targets related to a questionable AI data center deal. Papa John's is alleged to have misrepresented its strategic transformation progress and minimized business risks. Lead plaintiff deadlines are approaching for all cases.

Rosen Law Firm is notifying investors who purchased Ardelyx common stock between January 13, 2025 and August 6, 2026 of an important November 16, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Ardelyx provided false and misleading statements regarding commercial performance and growth prospects for its products XPHOZAH and IBSRELA, while concealing material facts about payer-related access barriers, prior authorization requirements, and step edit requirements that hindered patient access.

Rosen Law Firm has filed a class action lawsuit against D-Wave Quantum Inc. (NASDAQ: QBTS) on behalf of investors who purchased securities between February 26, 2026 and August 25, 2026. The lawsuit alleges that D-Wave made materially false and misleading statements regarding bookings decline in 2025, misrepresentation of 2026 bookings as new commercial adoption when they consisted of pre-Class Period contracts, failure to disclose pipeline conversion issues, and revenue delivery delays into Q4 2026 and 2027. The lead plaintiff deadline is December 15, 2026.

Rosen Law Firm announces a securities class action lawsuit against Hyliion Holdings Corp., alleging the company made false and misleading statements regarding its VFG Holdings partnership and commercial pipeline credibility. Investors who purchased HYLN stock between May 12, 2026 and June 23, 2026 may be eligible for compensation. The lead plaintiff deadline is October 27, 2026.

Rosen Law Firm has filed securities class action lawsuits against Innventure, Inc., Flotek Industries, Inc., and Hims & Hers Health, Inc., alleging materially false and misleading statements. Innventure is accused of overstating revenue targets related to Accelsius Holdings' deal with DarkNX. Investors have until specified deadlines in late October and early November 2026 to join the class actions.

Rosen Law Firm issued deadline notices for securities class action lawsuits against Flotek Industries (FTK), Innventure Inc. (INV), and Hims & Hers Health (HIMS). The lawsuits allege materially false and misleading statements regarding business operations and financial prospects. Lead plaintiff deadlines range from October 26 to November 2, 2026.

A securities class action lawsuit has been filed against Hims & Hers Health, Inc. alleging the company made materially false statements regarding consumer health data sharing with third-party advertisers, premature prescription charges despite promised consultations, and undisclosed regulatory scrutiny. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 may be eligible for compensation. The lead plaintiff deadline is November 2, 2026.

Coastal Financial Corporation faces a securities class action lawsuit alleging that executives made false statements about credit quality in its CCBX banking-as-a-service segment. The company reported a surprise $42.1 million net loss in Q2 2026, driven by a $68.8 million credit expense related to a $500 million partner loan portfolio that had materially deteriorated. The stock price fell over 43% following the disclosure. Investors with substantial losses can seek appointment as lead plaintiff by December 1, 2026.

Beta Bionics (NASDAQ: BBNX) is facing a securities class action lawsuit for allegedly concealing critical FDA compliance issues and device safety warnings. The complaint alleges the company failed to disclose over 18,000 unreported customer complaints regarding the iLet Bionic Pancreas, including algorithm failures and severe hypoglycemia events. Stock declined 37% on January 8, 2026 after missing patient start expectations, and further dropped following an FDA Warning Letter on February 24, 2026. The lead plaintiff deadline is November 3, 2026.

Robbins Geller has announced a December 8, 2026 deadline for investors to seek lead plaintiff status in a securities class action lawsuit against Millrose Properties, Inc. The lawsuit alleges that Millrose and its executives made false statements about the company's business operations, specifically regarding undisclosed lease agreements and $200 million in property purchases from Lennar that were being leased at a loss. The allegations emerged following an October 2, 2025 Hunterbrook Media report that triggered a 9% decline in Millrose's stock price.

Rosen Law Firm issued deadline notices for securities class action lawsuits against Unicycive Therapeutics (UNCY), York Space Systems (YSS), and Papa John's International (PZZA). The UNCY lawsuit alleges the company made false statements about manufacturing compliance and FDA approval prospects for its oxylanthanum carbonate drug. Investors have until specified deadlines in late October and early November 2026 to join the class actions.

A securities class action lawsuit has been filed against York Space Systems Inc. alleging that the company made materially false and misleading statements about its satellite software functionality. The lawsuit claims York Space's onboard mission and payload software was not fully functional before launch, deceived the Pentagon's Space Development Agency with false advertising, and delivered satellites with incomplete mission-critical software. Investors who purchased YSS securities during the class period must act by October 30, 2026 to serve as lead plaintiff.

Rosen Law Firm issued deadline notices for multiple securities class action lawsuits. Papa John's investors have until November 2, 2026 to join litigation alleging the company made false statements about its transformation strategy and concealed market share losses. Similar deadline notices were issued for York Space Systems (October 30 deadline) and Beta Bionics (November 3 deadline).

A securities class action lawsuit has been filed against Beta Bionics, Inc. alleging that the company made materially false and misleading statements about its iLet Bionic Pancreas insulin pump. The FDA reportedly raised serious concerns about the device malfunctioning and dosing patients with dangerously high insulin levels, causing hypoglycemic events. The lawsuit claims Beta Bionics failed to implement meaningful corrective actions despite thousands of complaints. Investors who purchased stock between July 30, 2025 and February 24, 2026 may be eligible for compensation, with a November 3, 2026 deadline to serve as lead plaintiff.

Bragar Eagel & Squire, P.C. announces class action lawsuits against Innventure, Inc. and other companies for allegedly making materially false and misleading statements. Innventure is accused of overstating revenue and cash flow targets related to Accelsius Holdings LLC's deal with DarkNX, which allegedly lacked evidence of feasibility. Investors who purchased securities during specified periods have until October 27, 2026 to apply as lead plaintiffs.

A class action lawsuit has been filed against Flotek Industries, Inc. for allegedly making false and misleading statements regarding a PREPA power generation project contract. The complaint claims the company failed to disclose credible doubts about the consortium parties' experience, organization, and financial capacity, and the risk that revenue from the contract would not be realized. Investors who purchased Flotek securities between August 3-17, 2026 have until October 26, 2026 to apply to be appointed as lead plaintiff.

Bragar Eagel & Squire, P.C. has filed class action lawsuits against XTI Aerospace, Innventure, and Flotek Industries for allegedly making materially false statements and failing to disclose undisclosed executive activities and disclosure control issues during their respective class periods. Investors have until October 27, 2026 to apply as lead plaintiffs.

A class action lawsuit has been filed against Hyliion Holdings Corp. for allegedly making false statements about a business deal with a recently formed entity lacking actual operations. The lawsuit claims CEO Thomas Healy and CFO Jon Panzer timed the announcement to facilitate insider trading, causing investor losses. The deadline to apply as lead plaintiff is October 27, 2026.

Rosen Law Firm is notifying Celsius Holdings investors of a November 3, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Celsius made false statements regarding cardiac risks of Alani Nu products and inappropriately marketed them to consumers under 18, creating potential liability and reputational damage.

Rosen Law Firm has filed securities class action lawsuits against DICK'S Sporting Goods, FuelCell Energy, and XTI Aerospace, alleging that defendants made materially false and misleading statements to investors. The firm is seeking lead plaintiffs and encouraging affected investors to secure counsel before upcoming deadlines.

Rosen Law Firm reminds XTI Aerospace investors who purchased securities between April 15, 2026 and August 17, 2026 of the October 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that senior executives engaged in undisclosed activities requiring Board review, raising doubts about disclosure controls and the company's ability to timely file earnings reports, making positive statements about the business materially misleading.

Sika reported strong nine-month results with 4.8% sales growth in local currencies and CHF 8.71 billion in reported sales. The company increased its material margin to 55.4% and maintained an EBITDA margin of 19.2%. The Fast Forward program is on track to deliver CHF 80 million in benefits by 2026. Sika completed the Akkim acquisition, acquired Azpects Group in the UK, and agreed to acquire Resonac Corporation's adhesives business in Japan. The company reiterated its 2026 guidance of 3-6% local currency growth and 19.0-19.5% EBITDA margin.

Rosen Law Firm announces a securities class action lawsuit against Innventure, Inc. (NASDAQ: INV) for investors who purchased securities between November 17, 2025 and August 13, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding Accelsius Holdings LLC's transformative deal with DarkNX, which was unlikely to materialize, and overstated revenue and cash flow targets for 2026. The lead plaintiff deadline is October 27, 2026.